Trials / Completed
CompletedNCT00060814
Combination Pharmacotherapy for Smoking Cessation Among Methadone Patients
Pilot Study Examining the Effects of Combined Pharmacotherapy (Zyban/NRT)/Behavioral Treatment on Smoking Cessation Among MMT Patients.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this pilot study is to examine the effects of combined pharmacotherapy (Zyban/NRT)/behavioral treatment on smoking cessation among methadone maintenance therapy patients.
Detailed description
This is a one-arm, open label pilot study of MMT patients to determine whether bupropion, nicotine replacement therapy, and behavioral counseling is a feasible and potentially effective intervention for smoking cessation. The smoking behaviors of participants will be be followed for 6 months post quit-date to determine effect-size estimates for a future, large scale trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Combined intervention | 300 mg bupropion plus 4mg nicotine gum ad lib plus motivational interviewing counseling |
Timeline
- Start date
- 2002-06-01
- Primary completion
- 2002-09-01
- Completion
- 2002-12-01
- First posted
- 2003-05-15
- Last updated
- 2017-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00060814. Inclusion in this directory is not an endorsement.